Stocks finished mixed Wednesday as President Donald Trump leveled harsh criticism at the $900 billion bipartisan coronavirus relief package just passed by Congress.
Here are some of the market's biggest gainers for Wednesday:
1. Supernus Pharmaceuticals | Percentage Increase 15%
Supernus Pharmaceuticals (SUPN) - Get Supernus Pharmaceuticals, Inc. Report shares jumped after the drugmaker focused on the central nervous system reported progress in a Phase 3 study of an attention-deficit-hyperactivity-disorder drug.
2. Energous | Percentage Increase 37%
Energous (WATT) - Get Energous Corp. Report was one of several clean energy companies that were boosted by provisions in the $900 billion bipartisan coronavirus relief package that feature such items as extensions on the solar and wind production tax credit.
The stimulus bill includes a $35.2 billion stipulation for alternative fuels and new energy technologies.
3. Ocugen | Percentage Increase 223%
Ocugen (OCGN) - Get Ocugen Inc Report shares tripled after the biopharma and Bharat Biotech announced plans to co-develop Covaxin, an advanced stage whole-viron inactivated vaccine candidate, for the U.S. market.
The drug has been evaluated in about 1,000 subjects in Phase 1 and Phase 2 clinical trials in India, with promising results.
4. Vivopower International | Percentage Increase 17%
Vivopower International (VVPR) - Get VivoPower International Plc Report rose after the company said it had proposed a $250 million Australian distribution agreement with GB Auto for Tembo light electric vehicles.
Under the terms of the agreement, Vivopower will be GB Auto’s partner of choice for any rental, lease or other financing solutions for the Tembo products or related sustainable energy solutions.
5. XL Fleet | Percentage Increase 86%
XL Fleet soared after the electric vehicle tech company closed on its merger with Pivotal Investment and began trading under the name XL Fleet Corp. and the ticker symbol XL.
XL Fleet received about $350 million in cash proceeds, which it plans to use to develop new products and for other purposes.